Jefferies Group LLC Arrowhead Pharmaceuticals, Inc. Put Options Transaction History

Jefferies Group LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2019 Feb 13, 2020	SELL	$28.14 - $73.01 $205,422 - $532,973	-7,300 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$26.26 - $34.86 $1.45 Million - $1.93 Million	-55,300 Reduced 88.34%	7,300 $206,000
Q2 2019 Aug 14, 2019	BUY	$17.43 - $28.82 $1.09 Million - $1.8 Million	62,600 New	62,600 $1.66 Million
Q4 2018 Feb 14, 2019	SELL	$10.74 - $19.7 $354,420 - $650,100	-33,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$14.0 - $20.3 $1.18 Million - $1.71 Million	-84,300 Reduced 71.87%	33,000 $633,000
Q2 2018 Aug 14, 2018	BUY	$6.37 - $14.02 $747,201 - $1.64 Million	117,300 New	117,300 $1.6 Million

294

90.8M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.01B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.